Evidence map›Paper›PMID 33414850›Full record

ReviewTherapeutic advances in musculoskeletal disease2020

A comprehensive review of the treatment and management of Charcot spine.

Ivan Urits, Ariunzaya Amgalan, Jacob Israel, Chase Dugay, Alex Zhao, Amnon A Berger, Hisham Kassem, Antonella Paladini, Giustino Varrassi, Alan D Kaye and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Therapeutic advances in musculoskeletal disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Charcot spinal arthropathy: a case series.Spinal cord series and cases · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Ivan UritsDepartment of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215, USA.ORCID https://orcid.org/0000-0002-3652-6085
Ariunzaya AmgalanGeorgetown University School of Medicine, MedStar Georgetown University Hospital, Washington, DC, USA.
Jacob IsraelGeorgetown University School of Medicine, MedStar Georgetown University Hospital, Washington, DC, USA.
Chase DugayCreighton University School of Medicine-Phoenix Regional Campus, Phoenix, AZ, USA.
Alex ZhaoGeorgetown University School of Medicine, MedStar Georgetown University Hospital, Washington, DC, USA.
Amnon A BergerDepartment of Anesthesiology, Beth Israel Deaconess Medical Center, Critical Care and Pain Medicine, Harvard Medical School, Boston, MA, USA.
Hisham KassemDepartment of Anesthesiology, Mount Sinai Medical Center of Florida, Miami, FL, USA.ORCID https://orcid.org/0000-0002-3729-1900
Antonella PaladiniDepartment MESVA, University of L'Aquila, L'Aquila, Italy.
Giustino VarrassiPaolo Procacci Foundation, Roma, Italy.
Alan D KayeDepartment of Anesthesiology, LSUHSC School of Medicine, Shreveport, Louisiana, USA.
Sumitra MiriyalaDepartment of Cellular Biology and Anatomy, LSUHSC School of Medicine, Shreveport, Louisiana, USA.
Omar ViswanathDepartment of Anesthesiology, LSUHSC School of Medicine, Shreveport, Louisiana, USA.
Georgetown University · USBeth Israel Deaconess Medical Center · USCreighton University · USLouisiana State University Health Sciences Center New Orleans · USFondazione Roma · ITMount Sinai Medical Center · USUniversity of L'Aquila · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Charcot spine arthropathy (CSA), a result of reduced afferent innervation, is an occurrence of Charcot joint, a progressive, degenerative disorder in vertebral joints, related mostly to spinal cord injury. The repeated microtrauma is a result of a lack of muscle protection and destroys cartilage, ligaments, and disc spaces, leading to vertebrae destruction, joint instability, subluxation, and dislocation. Joint destruction compresses nerve roots, resulting in pain, paresthesia, sensory loss, dysautonomia, and spasticity. CSA presents with back pain, spinal deformity and instability, and audible spine noises during movement. Autonomic dysfunction includes bowel and bladder dysfunction. It is slowly progressive and usually diagnosed at a late stage, usually, on average, 20 years after the first initial insult. Diagnosis is rarely clinical related to the nature of nonspecific symptoms and requires imaging with computed tomography (CT) and magnetic resonance imaging (MRI). Conservative management focuses on the prevention of fractures and the progression of deformities. This includes bed rest, orthoses, and braces. These could be useful in elderly or frail patients who are not candidates for surgical treatment, or in minimally symptomatic patients, such as patients with spontaneous fusion leading to a stable spine. Symptomatic treatment is offered for autonomic dysfunction, such as anticholinergics for bladder control. Most patients require surgical treatment. Spinal fusion is achieved with open, minimally-open (MOA) or minimally-invasive (MIS) approaches. The gold standard is open circumferential fusion; data is lacking to determine the superiority of open or MIS approaches. Patients usually improve after surgery; however, the rarity of the condition makes it difficult to estimate outcomes. This is a review of the latest and seminal literature about the treatment and chronic management of Charcot spine. The review includes the background of the syndrome, clinical presentation, and diagnosis, and compares the different treatment options that are currently available.

Indexed as

back painCharcot-Marie-Toothnerve root compressionspinal cord injuryspine denervationtabes dorsalis

Identifiers

PMID33414850
PMCPMC7750571
OpenAlexW3111664049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.